Turn Therapeutics Inc. (TTRX)
NGM · Healthcare · Biotechnology
$6.04
+3.16%
Closing price as of 2026-06-12 · Source: TEK2day Finance
Key Metrics
Market Cap
$154.9M
P/S (TTM)
nanx
Exchange
NGM
About Turn Therapeutics Inc.
Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. The company was formerly known as Global Health Solutions, Inc and change its name to Turn Therapeutics Inc. in September 2025. Turn Therapeutics Inc. was incorporated in 2015 and is based in Westlake Village, California.
Quarterly Financials
| Metric | 2025-03-31 | 2025-06-30 | 2025-09-30 | 2026-03-31 |
|---|---|---|---|---|
| Revenue | 0.00 | |||
| Operating Income | -1.4M | |||
| Net Income | -1.2M | |||
| Diluted EPS | $-0.01 | $-0.04 | $-0.06 | $-0.03 |
Annual Financials
| Metric | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Revenue | 0.00 | 0.00 | |
| Operating Income | -2.3M | -1.8M | |
| Net Income | -2.3M | -1.8M | |
| Diluted EPS | $-0.08 | $-0.06 | $-0.12 |